<?xml version="1.0" encoding="UTF-8"?>
<ref id="B69-marinedrugs-17-00373">
 <label>69.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Graf</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bernkop-Schnurch</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Eqyed</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Coller</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Prieschl-Grassauer</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Morokutti-Kurz</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Development of a nasal spray containing xylometazoline hydrochloride and iota-carrageenan for the symptomatic relief of nasal congestion caused by rhinitis and sinusitis</article-title>
  <source>Int. J. Gen. Med.</source>
  <year>2018</year>
  <volume>11</volume>
  <fpage>275</fpage>
  <lpage>283</lpage>
  <pub-id pub-id-type="doi">10.2147/IJGM.S167123</pub-id>
  <pub-id pub-id-type="pmid">30013382</pub-id>
 </element-citation>
</ref>
